Benoquin Injectables 0,6% (600 mg)

AED  6,800.00

Price per set of (10 vails) cost USD $1600,-

Benoquin Injectables are a patented product, based on 0,6% (600 mg) Monobenzone Powder assay 99,99 % compressed patented for oral / I.V. and I.M. usage. Monobenzone is a permanent depigmenting agent used primarily to treat vitiligo and lighten / whiten the healthy skin complexion irreversibly.

Categories

Benoquin Injectables are a patented product, based on 0,6% (600 mg) Monobenzone Powder assay 99,99 % compressed patented for oral / I.V. and I.M. usage. Monobenzone is a permanent depigmenting agent used primarily to treat vitiligo and lighten / whiten the healthy skin complexion irreversibly.

It’s mechanism consists of many biological mechanisms that result in severe reduced skin pigmentation.

Destruction of Melanocytes: Melanocytes produce melanin, the pigment that gives the skin its color. Monobenzone destroys melanocytes, reducing the amount of pigment-producing cells in the skin irreversibly.

Inhibition of Melanin Production: Melanin is the pigment that determines the color of the skin, hair, and eyes. Monobenzone inhibits the enzymatic mechanisms that produce melanin in melanocytes. It specifically inhibits the activity of tyrosinase, an enzyme required for melanin formation. The Benoquin Injectables will only target the skin NOT the eyes or the hear colour.

Increased Melanin Excretion: Monobenzone causes melanocytes to discharge melanin more quickly than usual, resulting in a loss of melanin in the skin. This technique helps lighten the skin by lowering the amount of pigment present.

The Benoquin Injectables 0,6% (600 mg) (Monobenzone), are an Intra Venous (I.V.) Intra Muscular (I.M.) medicine used largely to reduce skin pigmentation. Here are the common uses of monobenzone.

Vitiligo Treatment: Monobenzone is frequently recommended to individuals with severe vitiligo, a disorder marked by the loss of skin pigmentation in patches. It works by permanently depigmenting the remaining pigmented patches, resulting in a more even skin tone.

Occupational Depigmentation: In some industrial settings there were workers are working with “Occupational depigmentation,” or occupational vitiligo (or leukoderma), is a condition that occurs when workers are repeatedly exposed to certain industrial chemicals, primarily phenolic and catecholic derivatives, in the workplace. It is not a treatment or cosmetic procedure, but a potential health hazard in specific industrial settings. monobenzone has been used to intentionally depigment workers’ skin to prevent future contact dermatitis or allergic reactions induced by chemical exposure.

Some occupational sectors were we supply Benoquin Injectables and other Monobenzone products to are:

Rubber Manufacturing: Historically, the use of monobenzyl ether of hydroquinone (MBEH) as an antioxidant in rubber gloves was a major cause. The US rubber industry has largely stopped using this chemical, but it may still be present in products from other regions.

Chemical Manufacturing: Workers involved in making synthetic resins may be exposed to chemicals like 4-tert-butylphenol (4-TBP).

Healthcare/Janitorial Services: Exposure to germicidal detergents containing specific phenols can cause depigmentation in hospital workers.

Hair Salons: Hair dyes, specifically those containing para-phenylenediamine (PPD), have been reported to cause depigmentation on the scalp and face.

Leather & Textile Industries: Exposure to certain dyes and chemicals in leather goods (shoes, wallets) and other textiles has been implicated.

Woodworking: Certain types of wood dust, such as from Australian blackwood, have been reported as a risk factor in cabinet makers.

Hospitals (Dermatologists)

Veterinary sector: In order to depigment Lions, Snakes, Peacocks, Crocodiles etc… (Albino zoos / Pets)

Cosmetic uses: Benoquin Injectables 0,6% (600 mg) have approved by regulatory agencies due to extreme positive effects, however with the side effect of an ethical concern.

Usage of The Benoquin Injectables 0,6 % (600 mg):

  • A full course is 3 trays (3 × 10 vails) so, 30 vails in total.
  • Mode of administration is by I.V. (INTRA VENOUS) or I.M (INTRA MUSCULAR)
  • I.V. is the best. Just make sure to administrate the Benoquin Injectables 2 times a week by example every Monday and every Thursday.
  • The treatment will take 15 weeks, in week 16 (=4 months) the FIRST results will occur.

VERY IMPORTANT NOT TO SKIP ANY INJECTION IN THESE 15 WEEKS, OTHERWISE THE WHOLE TREATMENT IS IN VAIN (LOSS)

ICN-Benoquin Injectables 0,6% / 600 mg

Price: 10 vials 6800 AED

Reviews

There are no reviews yet.

Be the first to review “Benoquin Injectables 0,6% (600 mg)”

Your email address will not be published. Required fields are marked *

Reviews

There are no reviews yet.

Be the first to review “Benoquin Injectables 0,6% (600 mg)”

Your email address will not be published. Required fields are marked *